Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MPN Congress 2022 | Leveraging inflammatory cytokine signaling for therapeutic benefit in MPNs

Stephen Oh • 24 Nov 2022
MPN Congress 2022
Essential Thrombocythemia Myelofibrosis Myeloproliferative Neoplasms Polycythemia Vera Rare Diseases

Stephen Oh, MD, PhD, Washington University School of Medicine, Seattle, WA, gives a presentation on leveraging inflammatory cytokine signaling for therapeutic benefit in myeloproliferative neoplasms at the 14th International Congress on Myeloproliferative Neoplasms (MPNs) held in New York City, NY.

More from Stephen Oh

Targeting an aberrant DUSP6-RSK1 signaling axis driving MPN disease development & progression
Stephen Oh • 10 Nov 2022
1:09
The DUSP6-RSK1 pathway: a driver of disease progression in MPNs
Stephen Oh • 27 Aug 2022
1:07
Signaling pathways activated in MPNs: targeting the DUSP6-RSK1 pathway
Stephen Oh • 27 Aug 2022
3:25
Targeting dysregulated signaling networks for the treatment of MPNs
Stephen Oh • 12 Aug 2021

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
2:05
Donor lymphocyte infusion for relapsed myelofibrosis in the post-alloSCT setting
Alex Rampotas • 16 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals